8-Methoxypsoralen potentiates the photocytotoxic effect of Photofrin II towards EMT-6 murine tumor cells

Cancer Letters

Volumn 128, Issue 2, 1998, Pages 177-182

  Sousa, C ^a,b   Maziere C ^c   Melo, T S E ^a,b   Vincent Fiquet, O ^c   Rogez, J C ^c   Santus, R ^b   Maziere J C ^c  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b INSERM   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

8 Methoxypsoralen; Lipid peroxidation; Photodynamic therapy of tumors (PDT); Photofrin II

Indexed keywords

METHOXSALEN; PHOTOFRIN II; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; LIGHT EXPOSURE; LIPID PEROXIDATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; TUMOR CELL; ULTRAVIOLET A RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DIHEMATOPORPHYRIN ETHER; DRUG SYNERGISM; LIPID PEROXIDATION; METHOXSALEN; MICE; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

ANIMALIA; MURINAE;

EID: 0344863184     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00069-X     Document Type: Article

References (22)

1. J.S. McCaughan Jr., Clinical experience with PDT: a 5-year study, in: D. Kessel (Ed.), Photodynamic Therapy of Neoplastic Disease, Vol. I, CRC Press, Boca Raton, FL, 1990, pp. 21-41.
2. Dougherty T.J. Photodynamic therapy. Photochem. Photobiol. 58:1993;895-900.
3. Weishaupt K., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36:1976;2326-2329.
4. Lowdell C.P. Photodynamic therapy: an update. Clin. Oncol. 6:1994;79-80.
5. Henderson B., Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47:1987;3110-3114.
6. Chapman J.D., Stobbe C.C., Arnfield M.R., Santus R., Lee J., McPhee S. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res. 126:1991;73-79.
7. Pass H.I. Photodynamic therapy in oncology - mechanisms and clinical use. J. Natl. Cancer Inst. 85:1993;443-456.
8. Biade S., Mazière J.C., Santus R., Mora L., Mazière C., Auclair M., Morlière P., Dubertret L. Verapamil enhances the photocytotoxic effect of the anticancer porphyrin derivative Photofrin II in HT29 human adenocarcinoma cells. Cell. Pharmacol. 1:1993;37-41.
9. Biade S., Mazière J.C., Mora L., Santus R., Mazière C., Auclair M., Morlière P., Dubertret L. Lovastatin potentiates the photocytotoxic effect of Photofrin II in HT29 human colonic adenocarcinoma cells. Photochem. Photobiol. 57:1993;371-375.
10. R.M. Knobler, H. Hoenigsmann, R.L. Edelson, Psoralen phototherapies, in: F.P. Gasparro (Ed.), Psoralen DNA Photobiology, Vol. II, CRC Press, Boca Raton, FL, 1988, pp. 117-143.
11. T.B. Fitzpatrick, The psoralen story: photochemotherapy and photochemoprotection, in: T.B. Fitzpatrick, P. Forlot, M.A. Pathak (Eds.), Psoralens: Past, Present and Future of Photochemoprotection and Other Biological Activities, John Libbey Eurotext, London-Paris, 1989, pp. 5-9.
12. Biade S., Mazière J.C., Mora L., Santus R., Morlière P., Salmon S., Gatt S., Dubertret L. Photosensitization by Photofrin II delivered to Wi26VA4 SV40-transformed human fibroblasts by low density lipoproteins: inhibition of lipid synthesis and fatty acid uptake. Photochem. Photobiol. 55:1992;55-61.
13. Borenfreud E., Puerner J.A. A simple quantitative procedure using monolayer cultures for cytotoxicity assays. J. Tissue Cult. Methods. 9:1984;7-9.
14. Peterson G.A. A simplification of the protein assay of Lowry et al., which is more generally applicable. Anal. Biochem. 83:1977;346-356.
15. Candide C., Mazière J.C., Santus R., Mazière C., Reyftmann J.P., Morlière P., Goldstein S., Dubertret L. Photosensitization of Wi26 VA4 human transformed fibroblasts by the anticancer porphyrin mixture Photofrin II: evidence for endoplasmic reticulum alteration. Cancer Lett. 44:1989;157-161.
16. Morlière P., Moysan A., Santus R., Hüppe G., Mazière J.C., Dubertret L. UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim. Biophys. Acta. 1084:1990;261-268.
17. Yagi K. Lipid peroxides and human diseases. Chem. Phys. Lipids. 45:1987;337-351.
18. Girotti A.W. Photodynamic lipid peroxidation in biological systems. Photochem. Photobiol. 51:1990;497-509.
19. Matsuo I., Yoshimo K., Ohkido M. Mechanisms of skin surface lipid peroxidation. Curr. Probl. Dermatol. 11:1983;135-143.
20. Potapenko A.Y., Moshnin M.V., Krasnowsky A.A. Jr., Sukhorukov V.L. Dark oxidation of unsaturated lipids by the photooxidized 8-methoxypsoralen. Z. Naturforsch. 37c:1981;70-74.
21. Dall'Acqua F., Martelli P. Photosensitizing action of furocoumarins on membrane components and consequent intracellular events. J. Photochem. Photobiol. B Biol. 8:1991;235-256.
22. Gasparro F.P. Psoralen photobiology: recent advances. Photochem. Photobiol. 63:1996;553-557.